2024 Inova Fairfax MGR (Enduring Material): Novel Therapies for Cardiac Amyloidosis and Hypertrophic Cardiomyopathy- Targeting Myocardial Substrate

Topic: Novel Therapies for Cardiac Amyloidosis and Hypertrophic Cardiomyopathy: Targeting Myocardial Substrate

Learning Objectives

  • Advance education in basic scientific principles applicable to clinical situations.
  • Disseminate information regarding disease prevention and public health.
  • Improve understanding of psychosocial and legal issues as they apply to delivery of excellent patient care.
  • Provide updates in medical diagnosis and treatment to improve patient outcome.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
01/09/2024
Course expires: 
01/08/2025
Cost:
$0.00
Rating: 
0
Speaker(s)

Sumeet Mitter, MD, MSc, FACC

has a financial relationship (Consulting Fee) with Alnylam;.
has a financial relationship (Consulting Fee) with BridgeBio;.

Accreditation Statement

The Inova Office of Continuing Medical Education is accredited by the Medical Society of Virginia to provide continuing medical education for physicians.

Credit Designation Statement

The Inova Office of Continuing Medical Education designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Physicians may claim up to 1.0 credits in Type 1 CME on the Virginia Board of Medicine Continued Competency an

Available Credit

  • 1.00 AMA PRA Category 1 Credit

Price

Cost:
$0.00
Please login or register to take this course.